|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 100, 65-76, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
J Vinten-Johansen, V Chiantella, WE Johnston, BT Jolly, WD Kendricks, TO Hester and AR Cordell
Oxyradicals potentially limit the myocardial protection provided by blood
cardioplegia in ischemically damaged hearts. We tested the hypothesis that
the addition to blood cardioplegic solution of a new oxyradical
scavenger--N-(2-mercaptopropionyl)-glycine--would result in improved left
ventricular performance and oxygen consumption compared to that resulting
from the use of blood cardioplegia alone. Gauges and transducer-tipped
catheters for left ventricular minor axis ultrasonic dimension were placed
in 17 open-chest dogs, and instantaneous left ventricular pressure-diameter
data were acquired by computer. The aorta was crossclamped for 30 minutes
during total vented bypass to induce ischemic injury. The heart was
reoxygenated and protected by multidose, hypothermic blood cardioplegic
solution alone (n = 9) or enhanced with 0.0132 mmol
N-(2-mercaptopropionyl)-glycine (n = 8) for 1 hour of cardioplegia-induced
arrest. Preischemic and postischemic left ventricular performance was
measured by slope changes in end-systolic pressure-diameter relations
induced by gradual afterload reduction during right heart bypass. When
blood cardioplegia alone was used, postischemic left ventricular systolic
performance was depressed by 73.2% +/- 10.0% (166.8 +/- 56.1 mm Hg/mm
versus 25.1 +/- 7.0 mm Hg/mm). N-(2-mercaptopropionyl)-glycine did not
significantly attenuate this functional depression (62.7% +/- 9.0%, 146.6
+/- 67.6 mm Hg/mm versus 33.6 +/- 11.9 mm Hg/mm). The postischemic
end-diastolic pressure- diameter relation was shifted to the right, whereas
chamber stiffness was increased comparably, with or without
N-(2-mercaptopropionyl)- glycine. Postischemic oxygen consumption in the
beating working state, calculated from left ventricular blood flow
(measured by microspheres) and arterial-coronary sinus oxygen extraction,
averaged 7.8 +/- 0.9 ml O2/100 gm/min with blood cardioplegia alone and 7.5
+/- 1.0 ml O2/100 gm/min with N-(2-mercaptopropionyl)-glycine, and was
unchanged from paired preischemic values in both groups. We conclude (1)
that N-(2- mercaptopropionyl)-glycine added to blood cardioplegic solution
in the dose and delivery regimen tested did not improve ventricular
systolic and diastolic performance compared with blood cardioplegia alone
and (2) that postischemic oxygen consumption may not parallel the extent of
left ventricular functional recovery.
ARTICLES
Adjuvant N-(2-mercaptopropionyl)-glycine in blood cardioplegia does not improve myocardial protection in ischemically damaged hearts
Department of Cardiothoracic Surgery, Bowman Gray School of Medicine, Wake Forest University Medical Center, Winston-Salem, N.C. 27103.
This article has been cited by other articles:
![]() |
J. Poling, W. Rees, V. Mantovani, S. Klaus, L. Bahlmann, V. Ziaukas, N. Hubner, and H. Warnecke Evaluation of myocardial metabolism with microdialysis during bypass surgery with cold blood- or Calafiore cardioplegia. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 597 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Laub, S. Muralidharan, J. Reibman, J. Fernandez, W. A. Anderson, J. Gu, C. Daloisio, L. B. McGrath, and L. J. Mulligan ESMOLOL AND PERCUTANEOUS CARDIOPULMONARY BYPASS ENHANCE MYOCARDIAL SALVAGE DURING ISCHEMIA IN A DOG MODEL J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 1085 - 1091. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |